STUDY ON CLINICAL CHARACTERISTICS, ASSESSMENT OF DISABILITY LEVEL AND QUALITY OF LIFE OF PATIENTS WITH MIGRAINE

Văn Quân Nguyễn, Hồng Khôi Võ , Thị Nga Nguyễn

Main Article Content

Abstract

Background: Description of some clinical characteristics, assessment of disability level and quality of life (based on MIDAS AND HIT-6 score) of patients with migraine. Objective: 42 patients with Migraine who were diagnosed and treated in Neurology Department, Cua Dong General Hospital from February 2023 to October 2023. Method: Cross – sectional study. Result: The average age of the patient group was 41.33±11.34, female accounting for 73.8%. The average number of pain attacks in the latest month was 3.43±1.3, the average pain intensity according to the VAS score was 6.69±0.86 (of which 57.1% of patients had frequent severe pain). There were 23.8% of patients with aura signs, mainly visual symptoms. Some favorable factors that caused attacks including: weather (35.7%), anxiety and stress (33.3%), sleep (33.3%), light and noise (30.9%). 38.8% of female patients were reported pains related to menstrual cycle. The average MIDAS score was 28.90±8.02, of which rate of severe disability (MIDAS > 21 points) comprised 78.6% while percentage of moderate disability (MIDAS 11-20 points) took up 21.4%. The average HIT-6 score was 61.48±5.0; The migraine had serious, moderate and minor impact on quality of life of 69%, 16.7% and 14.3 % of above patients, respectively. Conclusion: Migraine is a common disease in young women with various severe headaches and diverse symptoms. The disease deeply affects quality of life and caused serious disability

Article Details

References

1. Arnold M. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
2. Zhang N, Robbins MS. Migraine. Ann Intern Med. 2023;176(1):ITC1-ITC16.
3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II. Headache: The Journal of Head and Face Pain. 2001;41(7):646-657.
4. Sacco S, Harriott AM, Ayata C, et al. Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update. Neurology. 2023;100(15):716-726.
5. Park JW, Chu MK, Kim JM, Park SG, Cho SJ. Analysis of Trigger Factors in Episodic Migraineurs Using a Smartphone Headache Diary Applications. PLoS One. 2016;11(2):e0149577.
6. Sun S, Liu C, Jia Y, et al. Association Between Migraine Complicated With Restless Legs Syndrome and Vitamin D. Front Neurol. 2021;12:777721.
7. Agosti R, Parzini C, Findling O, et al. Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study. Pain Ther. 2023;12(2):575-591.
8. Su P, Liu YC, Lin HC. Risk factors for the recurrence of post-semicircular canal benign paroxysmal positional vertigo after canalith repositioning. J Neurol. 2016;263(1):45-51.
9. Burow P, Meyer A, Naegel S, Watzke S, Zierz S, Kraya T. Headache and migraine in mitochondrial disease and its impact on life—results from a cross-sectional, questionnaire-based study. Acta Neurol Belg. 2021;121(5):1151-1156.
10. Vũ Anh Nhị, Nguyễn Thái Mỹ Phương (2014). Đặc Điểm Lâm Sàng và Đáp Ứng Điều Trị ở Bệnh Nhân Đau Đầu Migraine Mạn tính_Y Học TP. Hồ Chí Minh * Tập 18 * Phụ Bản Của Số 1.